At the end of the day, my priority is your health and well-being. Whether you're dealing with a complex urological issue or seeking advice on a sensitive matter, I am here to provide the expert care you need with the compassion and understanding you deserve.
Sexual Health & Wellbeing: Expert Urological Support
Sexual Health & Wellbeing
Evidence-based guidance on sexual wellbeing, desire and performance anxiety. Clear pathways to psychosexual support and NHS STI testing, PrEP/PEP and vaccines.
Sexual Health & Wellbeing: Understanding, Agency and Confidence
Sexual health isn't just about infections or dysfunction—it's about agency. The confidence to experience intimacy without fear. The knowledge to make informed decisions. And the clarity to understand when something needs attention.
As a urological surgeon specialising in andrology and psychosexual medicine, I treat conditions affecting sexual function—erectile dysfunction, premature ejaculation, hormonal imbalances, Peyronie's disease and the psychological dimensions of sexual performance. This hub provides evidence-based information to help you understand sexual wellbeing comprehensively, navigate concerns with clarity, and access the right support.
You are not alone. In England, there are around 2.3–2.4 million sexual health screens each year. People seek support not because something is "wrong", but because they value their health, their relationships and their peace of mind.
What This Hub Covers
Sexual wellbeing and desire
– understanding libido, connection and intimate satisfaction
Performance anxiety
– the mind-body connection in sexual function
Psychosexual concerns
– when psychological factors affect physical intimacy
STI awareness and education
– evidence-based guidance on testing, prevention and NHS services
Inclusive perspectives
– respecting all orientations, identities and relationship structures
Navigating Sexual Health Services
My practice provides: Assessment and treatment for sexual function issues (erectile dysfunction, performance anxiety, premature ejaculation, Peyronie's disease, hormonal concerns) and psychosexual counselling.
NHS sexual health services provide: STI testing, PrEP/PEP, contraception and vaccination. Find your local service at nhs.uk/service-search
Understanding Sexual Wellbeing Holistically
When patients consult me about sexual concerns, the presenting symptom—whether erectile difficulty, loss of desire or performance anxiety—rarely tells the whole story. Sexual wellbeing emerges from the interaction between physical health, psychological state and relationship dynamics.
An erection problem might stem from vascular disease, performance anxiety, or relationship stress—often all three. Loss of libido could reflect hormonal imbalance, chronic fatigue, medication effects, or unspoken relationship tension. Understanding these connections guides appropriate intervention.
The Three Pillars of Sexual Health
Physical foundations: Hormones, circulation, neurological function and medication effects influence sexual response. Conditions like diabetes or cardiovascular disease often manifest through sexual symptoms before other signs appear.
Physiological Mechanisms in Sexual Function
Sexual response requires coordinated physiological systems working in harmony.
Erectile function depends on vascular health (adequate arterial inflow and venous restriction), intact nerve pathways (autonomic and somatic), hormonal balance (primarily testosterone), and psychological arousal triggering nitric oxide release. When antihypertensive medications dampen sympathetic nervous activity to lower blood pressure, they simultaneously affect the pathways driving arousal and orgasm.
Similarly, diabetes damages small blood vessels throughout the body—penile arteries, with their narrow diameter, are particularly vulnerable. What presents as "erectile dysfunction" is often early vascular disease made visible through sexual function, sometimes years before cardiac symptoms emerge.
This interconnectedness means comprehensive assessment addresses the whole physiological context, not just isolated symptoms.
Psychological wellbeing: Stress, mood, self-image and past experiences shape how we approach intimacy. Performance anxiety, in particular, creates physiological responses that inhibit the very function being attempted.
The Neuroscience of Performance Anxiety
Anxiety triggers measurable neurochemical changes that inhibit sexual response.
When the brain perceives performance pressure, the amygdala activates the hypothalamic-pituitary-adrenal axis, releasing cortisol and adrenaline. These stress hormones redirect blood flow toward major muscle groups (preparation for fight or flight) and away from "non-essential" areas—including genital tissues. Simultaneously, adrenaline inhibits nitric oxide release, the key neurotransmitter responsible for vascular relaxation during arousal.
This creates a paradox: the harder you try to achieve arousal or orgasm, the more your stress response sabotages the mechanisms you need. The conscious mind knows this isn't life-threatening, but the amygdala doesn't distinguish psychological from physical danger. It triggers the same cascade whether facing genuine threat or anticipating sexual "failure".
Breaking this cycle requires teaching the nervous system that intimacy is safe, not threatening—through gradual positive experiences, mindfulness techniques shifting attention from outcome to sensation, and sometimes professional guidance to reframe expectations.
Relational dynamics: Even strong partnerships experience seasons of mismatch in desire, communication or emotional availability. Sexual wellbeing includes the capacity to discuss needs and vulnerabilities without blame or defensiveness.
Evidence-based insight: Couples who can talk openly about sex tend to report higher sexual satisfaction and relationship happiness over time. Communication doesn't guarantee perfection, but it creates space for understanding and mutual adaptation.
My role is helping you identify which pillar needs attention—recognising that sexual concerns rarely have single causes requiring single solutions.
Performance Anxiety: When Mind and Body Disconnect
Performance anxiety is one of the most common concerns I address, yet patients often feel uniquely isolated by it. The physiological mechanism is straightforward: stress activates the sympathetic nervous system, releasing adrenaline to prepare for danger. In that high-alert state, blood flow redirects toward major muscles and away from areas not needed for survival—including genital tissues.
Even when desire is present, the body may simply not cooperate. This isn't weakness or dysfunction—it's physiology responding exactly as evolution programmed it to respond to perceived threat.
The Jaguar in the Jungle: Understanding Threat Response
Modern stress triggers ancient survival mechanisms designed for physical danger.
Imagine encountering a jaguar in a jungle. Your amygdala instantly activates: pupils dilate, heart races, muscles tense, blood diverts to legs for running. Sexual arousal becomes physiologically impossible because reproduction is irrelevant when survival is threatened. This response kept our ancestors alive.
Now imagine the "jaguar" is performance pressure: a new partner, previous difficult experience, or simply the thought "what if I can't?" Your conscious mind knows this isn't life-threatening, but your amygdala doesn't distinguish psychological from physical danger. It triggers the same cascade—adrenaline surges, blood vessels constrict peripherally, arousal evaporates.
The cruelty of this mechanism is its self-reinforcing nature. One difficult experience creates worry about the next; that worry triggers the stress response that causes the very difficulty feared. Each "failure" strengthens the neural pathway linking intimacy with threat.
Breaking this cycle requires multiple approaches: gradual positive experiences that retrain the association, mindfulness techniques shifting focus from outcome to present sensation, understanding the mechanism to dissolve shame, and sometimes medication (PDE5 inhibitors) to interrupt the cycle mechanically while psychological work proceeds.
Importantly, medication alone—without addressing the psychological trigger—can reinforce the belief "I can't do this without help." Combining pharmacological and therapeutic approaches yields the most durable long-term outcomes.
Practical Approaches to Performance Anxiety
Treatment isn't about "trying harder"—it's about removing pressure and rebuilding confidence through structured, positive experiences. This might involve:
Reframing expectations:
Defining intimacy beyond penetration or orgasm
Sensate focus exercises:
Structured touch without performance goals
Mindfulness techniques:
Anchoring attention to present sensation rather than feared outcomes
Communication strategies:
Involving partners in understanding and supporting the process
Medical assessment:
Excluding physical factors that may compound psychological difficulty
Psychosexual therapy:
Professional guidance to identify and address underlying patterns
Clinical insight: Most people I see describe immediate relief simply from understanding the mechanism. The problem wasn't "broken equipment"—it was a normal physiological response to perceived threat. That understanding alone begins to dissolve the shame that perpetuates the cycle.
Libido is not a fixed personality trait—it's a dynamic conversation between hormones, neurochemistry, energy levels, relationship dynamics and life context. When desire fades, patients often feel alarm: "Something fundamental has changed about me." Usually, multiple factors have shifted simultaneously, creating a cumulative effect.
The Neurobiology of Desire
Sexual desire emerges from interaction between multiple neurochemical and hormonal systems.
Desire requires coordination between testosterone (baseline drive), dopamine (motivation and reward anticipation), oxytocin (bonding and trust), serotonin (mood regulation and anxiety modulation) and cortisol (stress response). Imbalance in any system can suppress overall desire.
For example: chronic stress elevates cortisol, which directly suppresses testosterone production and dampens dopamine signalling. Simultaneously, selective serotonin reuptake inhibitors (SSRIs)—commonly prescribed for anxiety and depression—can blunt dopamine-mediated reward pathways and delay orgasm through increased serotonin activity. The medication that improves mood may inadvertently dampen desire.
Sleep deprivation reduces testosterone by up to 15% within one week. Chronic pain redirects neural attention away from pleasure-seeking. Relationship resentment—even unspoken—creates emotional distance that translates to reduced physical desire.
This complexity explains why "low libido" assessment requires comprehensive evaluation: blood tests for testosterone, thyroid and prolactin; medication review; sleep quality assessment; relationship history; exploration of unspoken tensions or mismatched expectations.
Sometimes desire returns with testosterone optimisation; sometimes it requires couples therapy to address emotional disconnection; often it needs both, plus lifestyle modification addressing sleep, stress and physical activity.
Common Contributing Factors
Physiological: Low testosterone, thyroid dysfunction, anaemia, chronic illness, medication side effects (especially antidepressants and antihypertensives), chronic pain, sleep disorders.
Psychological: Depression, anxiety, chronic stress, body image concerns, past trauma, unresolved relationship conflict.
Contextual: Fatigue, work pressure, parenting demands, major life transitions, grief, financial worry.
Hormonal Assessment in Low Desire
Testosterone plays a role in desire, but it's rarely the complete answer.
Testosterone provides baseline drive—the physiological substrate for desire—but doesn't create psychological motivation for intimacy. A person with optimal testosterone but chronic relationship stress, depression or exhaustion will still experience low libido. Conversely, someone with modestly low testosterone but strong emotional connection, good sleep and low stress may function perfectly well.
This is why I don't prescribe testosterone based solely on numbers. If total testosterone is genuinely low (typically below 8-10 nmol/L, though reference ranges vary) and accompanied by fatigue, reduced muscle mass, mood changes or sexual symptoms, replacement therapy may restore function. But if testosterone is normal or borderline, supplementing won't help and may cause harm through side effects or suppression of natural production.
Assessment also considers free testosterone (the bioavailable fraction), SHBG (sex hormone binding globulin), prolactin (which suppresses desire when elevated), thyroid function, and metabolic markers. Sometimes the "hormonal problem" is actually untreated sleep apnoea, chronic stress elevating cortisol, or medication effects.
Rebuilding Desire
Treatment begins with identifying modifiable factors and prioritising realistic interventions:
Sleep optimisation:
Desire requires energy; chronic fatigue dulls every pleasure
Stress management:
Practical strategies, not platitudes—delegating tasks, setting boundaries, professional support
Physical activity:
Regular exercise improves circulation, mood, body confidence and testosterone regulation
Relationship communication:
Naming mismatches, expectations and unspoken tensions
Redefining intimacy:
Pleasure without pressure; connection without performance goals
Medical intervention:
Hormonal optimisation when indicated; medication review; treating underlying conditions
Even strong, loving partnerships experience seasons of sexual mismatch. One partner initiates while the other withdraws—both interpreting the pattern as rejection, neither understanding the other's internal experience. Busy lives reduce time for connection, replacing intimacy with logistics. Illness, fertility challenges or external stress shifts rhythms that once felt effortless.
These are relational dynamics, not personal failings. The couples I see in psychosexual therapy aren't "broken"—they've lost a shared language for discussing vulnerability, need and pleasure without defensiveness or blame.
Common Patterns I Encounter
Desire discrepancy: Different baseline desire levels create perceived rejection on both sides—the higher-desire partner feels unwanted; the lower-desire partner feels pressured. Neither is wrong; the mismatch creates tension.
Communication breakdown: Assumptions replace conversation. "If they loved me, they'd want this.""If I say no, they'll be hurt." Unspoken expectations accumulate into resentment.
Life-stage transitions: Parenthood, menopause, illness, bereavement, career changes—major shifts alter energy, body image, priorities and capacity for intimacy. Couples navigate these separately instead of collaboratively.
Cumulative disconnection: Small moments of missed connection—coming to bed at different times, prioritising screens over conversation—erode the emotional safety that intimacy requires.
The Role of Communication in Sexual Satisfaction
Good sexual communication isn't just "talking about sex"—it's creating safety for vulnerability.
Sexual communication requires capacity to express desire, pleasure, discomfort and boundaries without fear of rejection or judgement. It means listening without defensiveness when a partner expresses dissatisfaction. It involves negotiating mismatched desires with empathy rather than blame.
Many couples communicate well about logistics, shared goals and problem-solving but struggle to discuss sexual needs. The vulnerability required feels disproportionate to the risk. "What if they judge me? What if this truth damages us?"
Psychosexual therapy provides structured space for these conversations—a neutral setting where both partners feel heard, where concerns can be named without catastrophising, where differences become problems to solve collaboratively rather than evidence of incompatibility.
Research consistently demonstrates that couples who discuss sexual preferences, concerns and desires openly report higher long-term satisfaction. Communication doesn't guarantee constant passionate connection, but it creates resilience for navigating the inevitable fluctuations all long-term relationships experience.
Rebuilding Connection
Psychosexual therapy helps couples:
Name patterns without blame:
Identifying cycles of initiation/withdrawal or resentment/pressure
Understand underlying needs:
What each partner seeks through intimacy—validation, closeness, stress relief, pleasure
Negotiate differences:
Finding compromise when desires don't align perfectly
Rebuild non-sexual connection:
Structured exercises fostering affection and presence without performance pressure
Address individual factors:
How personal stress, health concerns or past experiences affect current patterns
Clinical observation: Most couples describe immediate relief just from naming their concern aloud in a neutral setting. The problem often isn't lack of love—it's lack of safe language for discussing vulnerability, disappointment and need.
Understanding STI Risk and Testing: An Educational Guide
As a urological surgeon, I frequently see patients with symptoms that raise STI concerns, or who present with anxiety after sexual exposure. While STI testing and treatment are provided through NHS sexual health services and specialist GUM clinics, understanding transmission, testing windows and when to seek help remains essential knowledge.
The internet is brilliant at turning "possible" into "probable". This section provides evidence-based information to restore perspective.
Where to Access STI Testing
NHS Sexual Health Services: Free, confidential testing for chlamydia, gonorrhoea, HIV, syphilis and other STIs. Find your local service at nhs.uk/service-search
Online postal testing: Free NHS home testing kits available through sexual health services for chlamydia and gonorrhoea.
Private GUM clinics: For rapid results or comprehensive screening packages outside NHS provision.
My practice: If urological symptoms (discharge, discomfort, lesions) require assessment alongside STI screening, I can coordinate care with appropriate testing services.
Understanding Transmission Risk
Not every sexual encounter carries equal risk. Unfortunately, online forums blur the distinction between theoretical possibility and real-world probability, creating disproportionate anxiety.
STIs transmit through vaginal, anal and oral sex, plus close genital-to-genital contact even without penetration. However, each infection behaves differently.
Infection-Specific Transmission Patterns
Transmission depends on pathogen type, contact site and multiple host factors.
Bacterial infections (Chlamydia, Gonorrhoea): Spread through direct mucous membrane contact—vagina, urethra, rectum, throat. Transmission risk varies by anatomical site, presence of symptoms, and bacterial load. Rather than speculating on probabilities, the practical approach is site-appropriate testing at appropriate times.
Viral infections requiring fluid exchange (HIV, Hepatitis B/C): HIV transmission depends heavily on viral load. If a person with HIV is on effective treatment and undetectable, there is effectively no risk of sexual transmission (U=U: Undetectable = Untransmittable). For untreated HIV, per-act transmission risk varies with type of sex (receptive anal intercourse carries higher risk than vaginal or insertive), presence of other STIs, and individual viral load. These multiple variables make single-number estimates misleading.
Skin-to-skin viruses (HPV, Herpes): Spread through direct contact with infected skin or mucosa. Condoms reduce but don't eliminate risk because they don't cover all potentially infectious areas. HPV is so prevalent that most sexually active people acquire at least one strain during their lifetime.
Understanding these patterns helps restore perspective without dismissing genuine concern—which is why appropriate testing matters regardless of calculated probabilities.
The Silent Nature of Most STIs
Many people expect pain, discharge or visible lesions to signal infection. In reality, most STIs cause no symptoms, especially early in their course. Chlamydia is asymptomatic in at least 50% of men and 70% of women; gonorrhoea can hide silently in the throat or rectum for months.
Why Infections Remain Silent
Asymptomatic infection isn't a flaw—it's evolutionary strategy.
Chlamydia trachomatis bacteria evolved to colonise epithelial cells without triggering inflammatory cascades that cause pain or discharge. They replicate inside cells, hidden from antibodies, provoking symptoms only when infection spreads to upper reproductive structures (epididymis, fallopian tubes) where inflammation finally becomes noticeable—often weeks or months after initial exposure.
From an evolutionary perspective, this stealth strategy is remarkably successful: asymptomatic carriers continue sexual activity, unknowingly transmitting infection to new partners. The pathogen thrives precisely because it doesn't announce its presence.
This is why symptom absence means nothing diagnostically. Screening is preventive medicine, not paranoia. Regular testing based on exposure history—not symptom presence—prevents complications and reduces transmission.
Testing: Accuracy and Timing
Modern molecular (NAAT/PCR) tests demonstrate high sensitivity—often over 95% for chlamydia and gonorrhoea—though performance varies by anatomical site and testing platform. Samples are straightforward: urine specimen, throat or genital swabs, and blood draw. Results typically arrive within 24–72 hours.
However, timing matters critically. Testing too early may miss infections below detection threshold—each pathogen has a "window period" before becoming visible on tests.
Window Periods and Testing Strategy
Window periods represent the gap between infection and detectability.
Infection: Chlamydia / Gonorrhoea | Earliest Detection: 5–7 days (NAAT) | UK Guideline Window: 2 weeks post-exposure | Notes: Retest if symptoms develop
Infection: Syphilis | Earliest Detection: 2–3 weeks (PCR on lesion) | UK Guideline Window: 6 weeks (serology) | Notes: 3-month retest if high suspicion
Infection: HIV (4th gen Ag/Ab) | Earliest Detection: Most by 4 weeks | UK Guideline Window: ~6 weeks (45 days) | Notes: Negative at 6 weeks generally conclusive
Infection: Hepatitis B | Earliest Detection: 3–4 weeks | UK Guideline Window: 6–8 weeks | Notes: 3-month follow-up if occupational exposure
Infection: Hepatitis C | Earliest Detection: 2–3 weeks (RNA) | UK Guideline Window: 8 weeks (antibody) | Notes: 3 months for definitive exclusion
Clinical strategy: Sexual health services often recommend dual testing—initial screen at two weeks for early reassurance, followed by confirmatory testing at six weeks for definitive exclusion. This balances psychological relief with diagnostic accuracy.
Prevention: Beyond Barrier Methods
Condoms and dental dams remain the most versatile STI protection. For specific infections, medical prevention adds powerful additional security.
PrEP (Pre-Exposure Prophylaxis): Daily or event-based tablet reducing HIV acquisition risk by around 99% when taken correctly. Available free through NHS sexual health services. Visit iwantprepnow.co.uk for information and access.
How PrEP Works
Understanding the mechanism of HIV prevention medication.
Tenofovir and emtricitabine are nucleoside reverse transcriptase inhibitors (NRTIs). When HIV enters a cell, it uses reverse transcriptase enzyme to convert its RNA genome into DNA for chromosomal integration. NRTIs masquerade as normal nucleotides but lack chemical bonds needed to extend the DNA chain—effectively terminating viral replication before infection establishes.
Daily dosing maintains steady tissue concentrations. Event-based dosing (2 tablets 2–24 hours before sex, 1 tablet 24 hours after, 1 tablet 48 hours after) achieves protective levels for specific encounters—highly effective when taken correctly, though mainly studied in gay and bisexual men.
Real-world effectiveness approaches 99% with high adherence. Rare transmission cases involved inconsistent dosing or drug resistance. PrEP works best as part of comprehensive sexual health strategy including regular monitoring.
PEP (Post-Exposure Prophylaxis): 28-day antiretroviral course started within 72 hours (ideally 24 hours) of potential HIV exposure. Available free through NHS sexual health services, A&E departments, or HIV clinics. Time-critical—contact services immediately if needed.
HPV Vaccination: Protects against strains causing 90% of genital warts and most HPV-related cancers (cervical, anal, oropharyngeal). Available for all genders, ideally before sexual debut but can still benefit adults depending on exposure history. Discuss with your GP or sexual health service.
Hepatitis B Vaccination: Provides long-lasting protection. Essential for healthcare workers and those with multiple partners. Often combined with Hepatitis A vaccine as single course.
Evidence insight: HPV vaccination in girls aged 12–13 has achieved 87% reduction in cervical cancer rates by age 25 compared to unvaccinated cohorts. Protection extends to adults already sexually active, though maximum benefit comes from pre-exposure vaccination.
When Anxiety Outlasts Risk
Sometimes worry about STI exposure persists despite multiple negative tests. Repetitive checking, constant googling of symptoms, avoiding intimacy for fear of contamination—these patterns suggest health anxiety rather than infection.
Health anxiety isn't attention-seeking. It's the brain's attempt to regain control through hypervigilance. When sexual health clinics have excluded infection but worry persists, psychosexual therapy can help separate thought patterns from medical reality.
Inclusive Sexual Health: Diversity in Orientation and Identity
Sexual health medicine should never require conforming to heteronormative assumptions. Inclusive care means asking about practices and needs rather than assuming based on appearance—recognising that anatomy doesn't dictate identity, orientation or pleasure.
Practical Inclusivity in Clinical Practice
When taking sexual history, clinicians should ask "where shall I take samples?" rather than assume based on perceived gender or relationship structure. If you've had oral sex, throat testing matters. If anal contact occurred, rectal sampling is indicated. This isn't political correctness—it's accurate medicine.
Why Anatomical Sites Matter for Testing
Infections behave differently depending on infection site.
Pharyngeal gonorrhoea often persists relatively long and can act as a reservoir for transmission—many people carry it asymptomatically for months. Rectal chlamydia is often asymptomatic (especially in women, and commonly in men who have sex with men), which is why site-based testing matters—untreated, it can cause proctitis and increase HIV susceptibility.
Standard "genital screening" using only urine samples would miss both. Comprehensive testing means sampling all sites of sexual contact, requiring clinicians to ask about practices without judgement or assumption.
This approach benefits everyone—gay, straight, bisexual, trans, non-binary—because it prioritises clinical accuracy over convention.
Sexual Wellbeing Across Identities
Sexual concerns don't respect identity categories. Erectile difficulty, desire discrepancy, performance anxiety and relationship communication challenges affect people of all orientations and gender identities. The physiological and psychological mechanisms remain consistent; the social context and available support may differ significantly.
Trans and non-binary individuals navigating sexual wellbeing may face additional layers: body dysphoria affecting intimacy, hormone therapy altering sensation or function, surgery recovery periods, finding language that fits personal experience, locating clinicians who understand gender-affirming care as inseparable from sexual health.
My practice approaches sexual function assessment without assumptions about gender identity or sexual orientation. The relevant questions are: What concerns you? What changed? What do you need? The answers guide investigation and treatment regardless of identity categories.
Evidence-based practice: When services are inclusive and non-judgemental, people are more likely to disclose relevant sexual practices and engage with appropriate site-based testing and prevention—improving clinical accuracy and continuity of care.
Resources and Support
Specialist organisations provide support for specific communities:
LGBT Foundation: lgbt.foundation – sexual health information, support services and advocacy
Stonewall: stonewall.org.uk – LGBTQ+ health resources and service directories
Terrence Higgins Trust: tht.org.uk – HIV and sexual health services for all communities
When to Seek Which Service
Sexual health encompasses multiple domains requiring different expertise. Understanding which service addresses which concern ensures appropriate, timely support.
Contact My Practice For:
Erectile dysfunction or performance concerns – comprehensive assessment combining physical examination, hormonal testing and treatment planning
Premature ejaculation or delayed ejaculation – medical and behavioural interventions
Loss of desire or libido issues – hormonal assessment, lifestyle review and psychosexual exploration
Performance anxiety affecting sexual function – psychosexual counselling individually or as a couple
Peyronie's disease or penile curvature – specialist urological assessment and treatment
Hormonal concerns – testosterone assessment and optimisation when clinically indicated
Relationship sexual difficulties – couple-focused psychosexual therapy
Body confidence affecting intimacy – therapeutic support addressing self-image and sexual wellbeing
Contact NHS Sexual Health Services For:
STI testing – chlamydia, gonorrhoea, HIV, syphilis, herpes and comprehensive screening
PrEP or PEP – HIV prevention medication with monitoring
Contraception and emergency contraception Pregnancy testing and referral
HPV, Hepatitis A/B vaccination
Partner notification support – confidential contact tracing services
Coordinated care: If your concern spans multiple domains—for example, erectile difficulty with STI exposure anxiety—I can coordinate assessment with appropriate sexual health services to ensure comprehensive, joined-up support.
Absolutely. Chronic stress activates the sympathetic nervous system, releasing adrenaline that redirects blood flow away from genital tissues. This physiological response makes arousal difficult even when desire is present. Addressing stress—through practical life changes, therapy, or medication when needed—often restores function without invasive intervention.
No. Testosterone provides baseline physiological drive, but desire emerges from interaction between hormones, neurochemistry, energy levels, relationship dynamics and life context. I assess testosterone as part of comprehensive evaluation, but wouldn't prescribe it without considering sleep quality, stress levels, medication effects, relationship satisfaction and psychological factors. Sometimes optimising these non-hormonal factors restores desire without medication.
Often yes. Even when there's physical cause—diabetes affecting circulation, for instance—anxiety about performance typically compounds the difficulty. Addressing psychological factors improves outcomes for both medical and purely psychological sexual concerns. I frequently combine medical treatment with psychosexual support for optimal results.
Consider testing after unprotected sex with new or casual partners, if a regular partner tests positive, when starting new relationships, before trying for pregnancy, or routinely every 6–12 months if sexually active with changing partners. Absence of symptoms doesn't indicate absence of infection—most STIs are silent, which is why screening based on exposure (not symptoms) prevents complications.
Desire discrepancy is one of the most common concerns in long-term relationships. It's rarely about love or attraction—it reflects different baseline drive levels, changing life circumstances, or communication difficulties. Couple-focused therapy helps partners understand each other's perspectives, negotiate differences without blame, and find sustainable compromise that respects both people's needs.
Yes. Many people recover through psychosexual therapy, mindfulness techniques, communication with partners and gradual positive experiences that retrain the nervous system's response. Medication (PDE5 inhibitors like sildenafil) can help interrupt the cycle initially, but combining pharmacological and therapeutic approaches—rather than relying solely on medication—yields the most durable long-term outcomes.
Persistent worry despite multiple negative tests often signals health anxiety rather than infection. This is a recognised psychological pattern where the brain becomes hypervigilant to perceived threats. Psychosexual or anxiety-focused therapy can help separate thought patterns from medical reality, reducing the compulsive checking that perpetuates worry.
The physiological mechanisms of desire, arousal and sexual response remain consistent across identities. However, social context, available support, body image concerns (particularly for trans individuals), and healthcare experiences may differ significantly. Inclusive care means asking about practices and needs rather than assuming based on appearance—ensuring everyone receives clinically accurate, respectful support.
Evidence-Based Insights
People on effective HIV treatment have the same life expectancy as those without HIV and cannot transmit the virus sexually (U=U: Undetectable = Untransmittable).
Performance anxiety activates the same stress response as physical danger, redirecting blood flow away from genital tissues—making arousal physiologically difficult even when desire is present.
Sleep deprivation can reduce testosterone levels by 15% in one week, directly affecting libido, energy and sexual responsiveness.
HPV vaccination in girls aged 12–13 achieved 87% reduction in cervical cancer rates by age 25 compared to unvaccinated cohorts.
Couples who discuss sexual preferences and concerns openly tend to report higher long-term satisfaction—communication creates resilience for navigating inevitable fluctuations.
Related Services and Conditions
Sexual wellbeing intersects with multiple aspects of urological and andrological care:
Sexual wellbeing is not peripheral to health—it's a fundamental indicator of how mind, body and relationships are functioning. When desire fades, function falters or anxiety dominates, these aren't isolated "sex problems"—they're signals that something in the broader system needs attention.
My role is helping you understand what's happening with clarity and compassion. Whether you need medical assessment for erectile function, hormonal evaluation for desire concerns, psychosexual therapy for performance anxiety, or simply information to make informed decisions, that support is available.
For concerns beyond my scope—STI testing, PrEP, contraception—NHS sexual health services provide excellent, confidential care. For sexual function and psychosexual wellbeing, my practice offers specialist expertise combining urological precision with psychological understanding.
The most powerful intervention I offer is often information itself—because understanding replaces fear, shame dissolves with knowledge, and clarity creates space for healing.
The Patient Information Forum is the UK membership organisation and network for people working in health information and support. The PIF TICK is the UK-wide Quality Mark for Health Information.
This content has been produced for educational purposes and reflects current evidence-based practice. Although GGO Med Ltd is a private urology service, all patient information is compiled with the aim of being accurate, evidence-based, and free from commercial bias. If you feel this content does not meet that standard, we would welcome your feedback — please contact us here.
